Home

Cardiology

Diabetes/Endocrinology

General Medicine

HIV/Infectious Diseases

Neurology

Oncology

Pulmonary Medicine

Real-world data show semaglutide benefit in type 2 diabetes

Miriam Tucker E. | Clinical Summary | 01 March 2023

Glycaemic control persists up to 720 days in both GLP-1RA experienced and naive people.

Takeaway

Real-world data demonstrate clinically significant glucose-lowering with the once-weekly subcutaneous human glucagon-like peptide-1 receptor agonist (GLP-1RA) semaglutide in adults with type 2 diabetes for up to 720 days in both GLP-1RA experienced and naive people.
Approximately 1 of 4 patients discontinued treatment during the first 6 months.

Why this...

Diabetes/Endocrinology

General Medicine

Lipids Management

Thyroid Disease

References

View all

5 PTS expert
What is the association between apolipoproteins and metabolic syndrome?

5 PTS expert
What are the maternal risk factors for cerebral palsy in children?

5 PTS expert
What is the association between 5α-reductase inhibitor use and prostate cancer mortality?

5 PTS expert
What are the effects of preoperative high-intensity interval training on cardiorespiratory fitness and postoperative settings?

5 PTS expert
What is the effect of infertility on men’s general health?

5 PTS expert
Depression, anxiety, and cancer risk: what’s the association?

5 PTS expert
Are proton pump inhibitors linked to serious infections in children?

5 PTS expert
Does maternal physical activity influence neonatal adiposity?

5 PTS expert
What is the risk of developing post-COVID-19 conditions in smokers?

5 PTS expert
What is the effect of beta-blockers and calcium channel blockers on rate control in atrial fibrillation?

5 PTS expert
What is the outcome of intravenous iron therapy in patients with iron deficiency and heart failure with reduced ejection fraction?

5 PTS expert
What are the effects of dexmedetomidine on postoperative nausea, vomiting, and bradycardia in adult patients under general anaesthesia?

5 PTS expert
What are the 1-year recovery rates for young people with depression and/or anxiety without any specific mental health treatment?

5 PTS expert
What are the standard and non-standard physical therapy outcomes for Parkinson’s disease management?

5 PTS expert
What is the association between successful percutaneous revascularisation of chronic total occlusions and quality of life?

5 PTS expert
What is the association between second-generation antiandrogens and the risk for cognitive toxic effects?

5 PTS expert
What are the office blood pressure treatment goals for patients aged ≥80 years?

5 PTS expert
What is the impact of human papillomavirus vaccine on anal human papillomavirus infection and anal intraepithelial neoplasia?

5 PTS expert
What are the effects of a vegetarian diet on the cardiometabolic profile of individuals at high risk for cardiovascular disease?

5 PTS expert
What is the most beneficial post-extubation non-invasive respiratory support for children?

5 PTS expert
Are you at risk of developing a post-COVID-19 condition?

5 PTS expert
What is the prevalence of potentially inappropriate medication use in older patients in outpatient services?

5 PTS expert
What is the effect of early emollient bathing on atopic dermatitis outcomes?

5 PTS expert
What are the postoperative transthoracic echocardiography recommendations before high-risk noncardiac surgery?

5 PTS expert
Four-strata risk assessment tool: how do you classify pulmonary arterial hypertension risk groups?

5 PTS expert
Which artificial sweeteners increase type 2 diabetes risk?

5 PTS expert
Is premature menopause linked to an increased risk for heart failure and atrial fibrillation?

5 PTS expert
How does parents’ psychiatric history influence preterm birth risk?

5 PTS expert
Depression and dementia: what’s the association?

View all

Quiz challenge Emerging diseases: COVID-19
Closed 10 Questions Available Ends on 1 October 2020

ESMO 2020 topic challenge
Closed 5 Questions Available Ends on 21 April 2021

Women's health challenge
Closed 10 Questions Available Ends on 12 May 2021

Antibiotics - Consequence of MDR carriage
Closed 6 Questions Available Ends on 12 May 2021

Neurological disorders challenge
Closed 10 Questions Available Ends on 12 June 2021

Rheumatology challenge
Closed 10 Questions Available Ends on 12 July 2021

Lyme Disease
Closed 11 Questions Available Ends on 12 July 2021

Mental health challenge
Closed 10 Questions Available Ends on 12 August 2021

Topic challenge - Children conditions
Closed 7 Questions Available Ends on 12 September 2021

Lyme Disease
Closed 11 Questions Available Ends on 12 September 2021

View all

Real-world data show semaglutide benefit in type 2 diabetes

November Challenge

Topic Challenges